Compare LIC MF Healthcare Fund vs SBI Healthcare Opportunities Fund
LIC MF Healthcare Fund
EquitySectoral-Pharma
SBI Healthcare Opportunities Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
1.0
5.0
Min SIP Amount
₹200
₹500
Expense Ratio
2.72
1.98
NAV
₹37.43
₹608.26
Fund Started
08 Feb 2019
04 Jun 1999
Fund Size
₹99.36 Cr
₹5870.00 Cr
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Exit load of 0.50% if redeemed within 15 days
1 Year
12.81%
21.11%
3 Year
20.64%
24.00%
5 Year
12.29%
18.51%
Equity
97.53%
95.53%
Cash
2.47%
4.41%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.59% |
Divi's Laboratories Ltd. | 9.07% |
Neuland Laboratories Ltd. | 6.14% |
Torrent Pharmaceuticals Ltd. | 6.04% |
Apollo Hospitals Enterprise Ltd. | 5.75% |
Aurobindo Pharma Ltd. | 5.23% |
Navin Fluorine International Ltd. | 4.98% |
Zydus Lifesciences Ltd. | 4.97% |
Aster DM Quality Care Ltd. | 4.61% |
Fortis Healthcare Ltd. | 3.77% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.14% |
Divi's Laboratories Ltd. | 7.91% |
Acutaas Chemicals Ltd. | 5.03% |
Apollo Hospitals Enterprise Ltd. | 4.45% |
Torrent Pharmaceuticals Ltd. | 4.42% |
Cipla Ltd. | 4.40% |
Laurus Labs Ltd. | 4.05% |
Max Healthcare Institute Ltd. | 3.80% |
Aurobindo Pharma Ltd. | 3.42% |
Aster DM Quality Care Ltd. | 3.21% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
08 Feb 2019
04 Jun 1999
